Navarra is emerging as one of the most dynamic Biomedical clusters in Spain, and it offers interesting opportunities for investment and association in the sector.
Navarra is home to CIMA, the biggest private biomedical research center in Spain. It employes more than 400 researchers from over 20 countries and receives annual investments of more than 20 million euros.
Some of the most attractive companies in Spain are in the Biomedical cluster, for example:
- 3P Biopharmaceuticals, the first CDMO (contract development manufacturing organization) in Spain.
- CINFA, a leader in the sale of generic medicines in Spain.
The Biomedial Cluster of Navarra has undergone constant expansion, with new business initiatives at both local level and from outside the region. Nowadays it includes more than 20 companies and research centers employing over 1,000 people. In the last 10 years the number of employees has doubled.
Furthermore, more than 60 patents have won awads during this period.
Biomedical scientific research in Navarra has a long tradition, developed around the Universidad de Navarra and its Schools of Medicine, Science and Pharmacy. The biomedical cluster was initially created around the Applied Medical Research Center (CIMA), where most of the biomedical R&D of the Universidad de Navarra has been carried out, together with a group of companies that emerged from this initiative.
Nowadays, the region has two prestigious universities with a long academic tradition, a prestigious public-private health system that is strongly linked to the universities and other stakeholders that promote applied research, such as the abovementioned CIMA and the Institute of Agrobiotechnology (IdAB).